2015 July 15, Pascal Rowart et al., “Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury”, in Journal of Immunology Research, volume 2015, →DOI:
MVs have been already tested in AKI model and appear to induce nephroprotection similarly to MSC administration.